Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology

Overview

Journal Geburtshilfe Frauenheilkd

Specialty Gynecology & Obstetrics

Date 2015 Dec 8

PMID 26640282

Citations 9

Authors

M P Lux

P A Fasching

C R Loehberg

S M Jud

M G Schrauder

M R Bani

F C Thiel

C C Hack

T Hildebrandt

M W Beckmann

Affiliations

Soon will be listed here.

Abstract

In the era of cost increases and reduced resources in the German healthcare system, the value of health services research and health economics is increasing more and more. Health services research attempts to develop concepts for the most effective ways to organise, manage, finance and deliver high-quality care and evaluates the implementation of these concepts with regard to daily routine conditions. Goals are the assessment of benefits and the economic advantages and disadvantages of new and established diagnostic methods, drugs and vaccines. Regarding these goals, it is clear that health services research goes hand in hand with health economics, which evaluates the benefits of diagnostic and therapeutic procedures in relation to the costs. Both scientific fields have focus principally on gynaecology and particularly on gynaecological oncology in Germany, as can be seen by numerous publications. These present several advantages compared with clinical trials - they uncover gaps in health care, question the material, staffing and consequently the financial resources required and they allow the estimation of value and the comparison of different innovations to identify the best options for our patients.

Citing Articles

Can a University Reproductive Medicine Centre Be Financed Under the Pre-Existing General Conditions in Germany?.

Hildebrandt T, Oversohl N, Dittrich R, Lotz L, Beckmann M, Lux M Geburtshilfe Frauenheilkd. 2019; 79(1):63-71.

PMID: 30686835 PMC: 6336462. DOI: 10.1055/a-0749-9103.

Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers.

Formago M, Schrauder M, Rauh C, Hack C, Jud S, Hildebrandt T Geburtshilfe Frauenheilkd. 2017; 77(8):879-886.

PMID: 28845052 PMC: 5570589. DOI: 10.1055/s-0043-114427.

Advances in Breast Cancer - Looking Back over the Year.

Luftner D, Lux M, Maass N, Schutz F, Schwidde I, Fasching P Geburtshilfe Frauenheilkd. 2015; 72(12):1117-1129.

PMID: 26640285 PMC: 4651151. DOI: 10.1055/s-0032-1328084.

Breast Cancer 2012 - New Aspects.

Kolberg H, Luftner D, Lux M, Maass N, Schutz F, Fasching P Geburtshilfe Frauenheilkd. 2014; 72(7):602-615.

PMID: 25324576 PMC: 4168404. DOI: 10.1055/s-0032-1315131.

Key Informants' Perspectives on Accredited Breast Cancer Centres: Results of a Survey.

Kowalski C, Wesselmann S, Ansmann L, Kreienberg R, Pfaff H Geburtshilfe Frauenheilkd. 2014; 72(3):235-242.

PMID: 25308982 PMC: 4168333. DOI: 10.1055/s-0031-1298249.

References

Mueller A, Boosz A, Koch M, Jud S, Faschingbauer F, Schrauder M . The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center. Arch Gynecol Obstet. 2011; 285(1):123-7. DOI: 10.1007/s00404-011-1905-y. View

Bijen C, de Bock G, Mourits M . Re: Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study. Gynecol Oncol. 2009; 113(2):295. DOI: 10.1016/j.ygyno.2008.12.002. View

Hershman D, Shao T, Kushi L, Buono D, Tsai W, Fehrenbacher L . Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2010; 126(2):529-37. PMC: 3462663. DOI: 10.1007/s10549-010-1132-4. View

Pfandzelter R, Wulfing U, Boedeker B, Heywang-Kobrunner S . [Diagnostic image quality of mammograms in german outpatient medical care]. Rofo. 2010; 182(11):993-1000. DOI: 10.1055/s-0029-1245587. View

Skinner K, Helsper J, Deapen D, Ye W, Sposto R . Breast cancer: do specialists make a difference?. Ann Surg Oncol. 2003; 10(6):606-15. DOI: 10.1245/aso.2003.06.017. View

Lux M, Reichelt C, Karnon J, Tanzer T, Radosavac D, Fasching P . Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System. Breast Care (Basel). 2012; 6(5):381-389. PMC: 3357170. DOI: 10.1159/000333118. View

Beckmann M, Bani M, Loehberg C, Hildebrandt T, Schrauder M, Wagner S . Are Certified Breast Centers Cost-Effective?. Breast Care (Basel). 2010; 4(4):245-250. PMC: 2941653. DOI: 10.1159/000229190. View

Brown S, Mallon E, Edwards J, Campbell F, McGlynn L, Elsberger B . Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997. Br J Cancer. 2009; 100(5):807-10. PMC: 2653769. DOI: 10.1038/sj.bjc.6604934. View

Lux M, Fasching P, Schrauder M, Lohberg C, Thiel F, Bani M . The era of centers: the influence of establishing specialized centers on patients' choice of hospital. Arch Gynecol Obstet. 2010; 283(3):559-68. DOI: 10.1007/s00404-010-1398-0. View

10.

Valachis A, Polyzos N, Nearchou A, Lind P, Mauri D . Financial relationships in economic analyses of targeted therapies in oncology. J Clin Oncol. 2012; 30(12):1316-20. DOI: 10.1200/JCO.2011.38.6078. View

11.

Coyle D, Grunfeld E, Coyle K, Pond G, Julian J, Levine M . Cost effectiveness of a survivorship care plan for breast cancer survivors. J Oncol Pract. 2013; 10(2):e86-92. DOI: 10.1200/JOP.2013.001142. View

12.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L . Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess. 2007; 11(26):iii-iv, ix-xi, 1-134. DOI: 10.3310/hta11260. View

13.

Mueller A, Thiel F, Lermann J, Oppelt P, Beckmann M, Renner S . Feasibility and safety of total laparoscopic hysterectomy (TLH) using the Hohl instrument in nonobese and obese women. J Obstet Gynaecol Res. 2010; 36(1):159-64. DOI: 10.1111/j.1447-0756.2009.01112.x. View

14.

Hillner B, Smith T, Desch C . Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000; 18(11):2327-40. DOI: 10.1200/JCO.2000.18.11.2327. View

15.

Beckmann M, Brucker C, Hanf V, Rauh C, Bani M, Knob S . Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients. Onkologie. 2011; 34(7):362-7. DOI: 10.1159/000329601. View

16.

Forbes J, Cuzick J, Buzdar A, Howell A, Tobias J, Baum M . Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2007; 9(1):45-53. DOI: 10.1016/S1470-2045(07)70385-6. View

17.

Regan M, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L . Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncol. 2011; 12(12):1101-8. PMC: 3235950. DOI: 10.1016/S1470-2045(11)70270-4. View

18.

Diedrich K, Strowitzki T, Kentenich H . The State of Reproductive Medicine in Germany. Geburtshilfe Frauenheilkd. 2017; 72(3):225-234. PMC: 5396528. DOI: 10.1055/s-0031-1298358. View

19.

Mueller A, Oppelt P, Ackermann S, Binder H, Beckmann M . The Hohl instrument for optimizing total laparoscopic hysterectomy procedures. J Minim Invasive Gynecol. 2005; 12(5):432-5. DOI: 10.1016/j.jmig.2005.04.006. View